CAMBRIDGE, England and SAN FRANCISCO, June 22, 2011 /PRNewswire/ -- Autonomy Corporation plc (LSE: AU. or AU.L), a global leader in infrastructure software for the enterprise, today announced that the website of leading Swiss pharmaceutical company Actelion, powered by Autonomy's flagship Web Content Management (WCM) platform, has twice consecutively been named the winner of the Swiss Pharma Site Monitor performance report. The Swiss Pharma Site Monitor report, which provides a unique combination of insights on key competences, ranging from web diagnostic reporting and usability to online strategy and management, cites Actelion's website, www.actelion.com, as "a clear example that other companies can look up to."
Headquartered in Switzerland, Actelion is a biopharmaceutical company focusing on the discovery, development and commercialization of innovative treatments to serve high, unmet medical needs. Actelion has subsidiaries in 29 countries, covering all major pharmaceutical markets worldwide. The company leverages Autonomy's meaning-based WCM solution to effectively manage and optimize web content segmentation and delivery in order to meet the customer experience needs of its diverse target groups.
Powered by the Intelligent Data Operating Layer (IDOL), Autonomy WCM is the industry's only solution to leverage pattern-based technology to form, in real-time, a conceptual and contextual understanding of all customer interactions from multiple channels, and enable the automatic delivery of optimized online content. Autonomy TeamSite allows Actelion employees to create and deliver the content on its website from an intuitive, unified interface, while Autonomy LiveSite enables the creation of dynamic, interactive and targeted sites for any purpose, such as a special corporate announcement. By enabling Actelion employees to easily create and dynamically deliver highly-targeted, consistent, and engaging web content, Autonomy's WCM solution was able to seamlessly support a comprehensive creative re-design of the Actelion website in early 2011.
The Swiss Pharma Site Monitor utilizes an objective, state-of-the-art benchmarking system that weighs all criteria relevant for the success of a website, which it divides into the three main areas of 'quality', 'usability', and 'business value'. In its latest 2011 report, the Swiss Pharma Site Monitor evaluated over a hundred websites operated by pharmaceutical companies in Switzerland, and named www.actelion.com 'Overall Winner by Total Score', after having previously awarded the website the same standing in 2010. The report cites Actelion's website as possessing "consistent strength across multiple disciplines," allowing it to "clearly leave the competition trailing in its wake."
"Since the implementation of Autonomy's WCM platform, Actelion's website has been awarded the highest ranking by the Swiss Pharma Site Monitor twice in a row. It has also undergone comprehensive creative redesign," commented Actelion. "Autonomy WCM has had a pivotal role in making this a reality by giving us a powerful, intelligent and easy-to-use online marketing platform for managing our strategic initiatives and significantly reducing time to web."
"As the industry's most integrated and comprehensive solution, Autonomy WCM enjoys a track record of powering over 20,000 websites worldwide, including those of some of the largest global brands," said James Murray, VP Autonomy Promote Solutions EMEA. "The fact that one of these websites, Actelion, has twice been independently recognized for its excellence is a further testament to the concrete benefits of the Autonomy solution."
As a future extension to its longstanding partnership with Autonomy, Actelion plans to adopt more of Autonomy's meaning-based platform for enterprise search and analytics, also powered by IDOL, to penetrate all information silos, derive maximum value from corporate assets, and boost employee productivity, while minimizing the risks endemic to information proliferation.
Please visit www.autonomy.com/wcm to find out more.
About AutonomyAutonomy Corporation plc (LSE: AU. or AU.L), a global leader in infrastructure software for the enterprise, spearheads the Meaning Based Computing movement. IDC recently recognized Autonomy as having the largest market share and fastest growth in the worldwide search and discovery market. Autonomy's technology allows computers to harness the full richness of human information, forming a conceptual and contextual understanding of any piece of electronic data, including unstructured information, such as text, email, web pages, voice, or video. Autonomy's software powers the full spectrum of mission-critical enterprise applications including pan-enterprise search, customer interaction solutions, information governance, end-to-end eDiscovery, records management, archiving, business process management, web content management, web optimization, rich media management and video and audio analysis.
Autonomy's customer base is comprised of more than 25,000 global companies, law firms and federal agencies including: AOL, BAE Systems, BBC, Bloomberg, Boeing, Citigroup, Coca Cola, Daimler AG, Deutsche Bank, DLA Piper, Ericsson, FedEx, Ford, GlaxoSmithKline, Lloyds TSB, NASA, Nestle, the New York Stock Exchange, Reuters, Shell, Tesco, T-Mobile, the U.S. Department of Energy, the U.S. Department of Homeland Security and the U.S. Securities and Exchange Commission. More than 400 companies OEM Autonomy technology, including Symantec, Citrix, HP, Novell, Oracle, Sybase and TIBCO. The company has offices worldwide. Please visit www.autonomy.com to find out more.
Autonomy and the Autonomy logo are registered trademarks or trademarks of Autonomy Corporation plc. All other trademarks are the property of their respective owners. Autonomy Editorial Contacts:Maria Chotreva
David VindelAutonomy (UK)
The Red Consultancy (UK) +44 207 104 5745
+ 44 207 025 email@example.com
firstname.lastname@example.org Edward Bridges
Louise KehoeFinancial Dynamics (UK)
Ogilvy PR (US)+44 207 831 3113
+1 415 677 email@example.com
|SOURCE Autonomy Corporation plc|
Copyright©2010 PR Newswire.
All rights reserved